Chao Hong Hu
Plus aucun poste en cours
Fortune : 96 M $ au 30/04/2024
Profil
Chao Hong Hu was the founder and the Chairman & General Manager of Shanghai Miracogen, Inc., which was founded in 2014.
Dr. Hu also held the position of Co-Chief Executive Officer & Executive Director at Lepu Biopharma Co., Ltd.
from 2020 to 2024.
Prior to that, Dr. Hu worked as the Director-Molecular Biology & Clinical Immunology at ID Biomedical Corp.
Dr. Hu also served as the Director-Bioassay Development & Process Analytics at Seagen Inc. from 2007 to 2013, and as the Head-Molecular Biology & Clinical Immunology at GSK Plc in 2006.
Dr. Hu obtained an undergraduate degree from Wuhan University in 1986.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
15/12/2023 | 136 355 106 ( 8,49% ) | 96 M $ | 30/04/2024 |
Anciens postes connus de Chao Hong Hu
Sociétés | Poste | Fin |
---|---|---|
LEPU BIOPHARMA CO., LTD. | Directeur Général | 31/01/2024 |
SEAGEN INC. | Corporate Officer/Principal | 01/10/2013 |
GSK PLC | Corporate Officer/Principal | 01/05/2007 |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01/01/2005 |
Shanghai Miracogen, Inc.
Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Directeur Général | - |
Formation de Chao Hong Hu
Wuhan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
LEPU BIOPHARMA CO., LTD. | Health Technology |
GSK PLC | Health Technology |
Entreprise privées | 3 |
---|---|
Shanghai Miracogen, Inc.
Shanghai Miracogen, Inc. BiotechnologyHealth Technology Part of Lepu Biopharma Co., Ltd., Shanghai Miracogen, Inc. is a Chinese company that engages in the development, clinical research, and industrialization of cancer targeted therapy drugs. The company is based in Pudong, China. The company was founded in 2014 by Chao Hong Hu and Marry Hu. Marry Hu has been the CEO since 2014. | Health Technology |
Seagen Inc.
Seagen Inc. Pharmaceuticals: MajorHealth Technology Seagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also focuses on the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. | Health Technology |
ID Biomedical Corp.
ID Biomedical Corp. Medical SpecialtiesHealth Technology ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada. | Health Technology |